Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Pulmonary > ILD > Flashcards

ILD Flashcards

1
Q

Path buzzword: UIP

A

Lymphoplasmacytic inflammation with fibroblastic foci and honeycomb change
–Temporal heterogeneity (juxtaposition of fibrosis and normal lung)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Path buzzword: LIP

A

Dense accumulation or “sheets” of lymphocytes and plasma cells within interstitium and alveolar spaces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Path buzzword: RBILD

A

accumulation of pigmented macrophages within respiratory bronchioles and alveolar ducts with bronchiolcentric distribution
-No significant fibrosis, interstitial inflammation, germinal centers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Path buzzword: DIP

A

Similar to RBILD but with alveolar spaces uniformly filled of pigmented macrophages. Homogeneous filling with preserved alveolar architecture and minimal fibrosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Features consistent with UIP

A
  1. Basal and subpleural predominant
  2. Reticular opac (with traction supportive of fibrosis)
  3. Honeycombing
  4. Absences of Inconsistent Features
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Inconsistent with UIP

A
  1. GGO (outside areas of fibrosis)
  2. Mosaicism/air trapping
  3. Nodules- centrilobular, perilymphatic
  4. Parahilar, peribronchovascular
  5. Upper lobe distribution
  6. Peripheral fibrosis with minimal honeycombing, subpleural sparing
  7. lower lobe distribution, not subpleural
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mutation leading to PAM

A

SLC34A2; autosomal recessive

Type IIb sodium-phosphate cotransporter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

PAP associated with Ab against

A

GM-CSF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Genetic pulmonary fibrosis:

A

hTERT and hTR are AD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pathologic hallmark of NSIP

A

cellular infiltrate with temporal uniformity

BAL lymphocytosis >20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

RB-ILD pathology

A

Pigmented alveolar macrophages in and around respiratory bronchioles and surrounding alveoli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DIP pathology

A

alveolar spaces uniformly filled with pigment-laden macrophages. Homogenous with preserved alveolar architecture and minimal fibrosis or honeycombing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

LIP Pathology

A

interstitial and bronchovascular infiltrate of lymphocytes and plasma cells. Can have poorly formed granulomas and multinuc giant cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

PLCH: diagnosis

-IHC

A

BAL with >5% CD1a positive cells

-IHC with CD1a and S-100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

PLCH: pathology

A

bronchiolocentric stellate lesions with central scar; intracellular inclusions (Birbeck granules) on EM, extensive Eos in early phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

LAM: pathology

A

hamartomatous proliferation of atypical smooth muscles along lymphatics in lung, thorax, abdomen/pelvis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

LAM: Cell expression

A

HMB-45; CD-63 on
1. myofibroblast-like spindle-shaped cells 2. epithelioid-like polygonal cells

-just spindle-shaped cells: muscle alpha-actin, vimentin, desmin (on )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

BAL Findings in IIP:

1. NSIP

A

BAL with >20% lymphs (overlap with HP and drug-induced)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

BAL Findings in IIP:

COP

A

Charac mixed pattern: lymphocytes (20-40%), neutrophil (10%), and Eos (5%) with some plasma/mast cells
-CD4/CD8 is decreased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

BAL Findings in IIP:

PLCH

A

> 5% CD1a-positive cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

BAL Findings in IIP:

AEP

A

> 25% Eos, normal periph Eos

-Tbbx with marked eosinophilic infiltration of alveoli and interstitium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

BAL Findings in IIP:

CEP

A

> 25% Eos

-Tbbx whos eosinophilic microabscesses, low grade vasculitis, and interstitial fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Nintedanib

  1. Mech
  2. Side effects
A

TK receptor blockers- mediate fibrogenic growth factors (PDGF, VEGF, FGF)

Diarrhea and LFT derangements, CytP3A4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Pirfenidone

  1. Mech
  2. Side effects
A
  1. Antifibrotic agent, inhibits TGF-b stimulated collagen synthesis, block fibro last proliferation
  2. nausea, rash
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Mutations leading to IPF
hTERT, hTR, Muc 5B
26
HRCT RB-ILD vs DIP
1. RBILD: fine centrilobular nodules, bilat patch GGOs upper and lower lung zones. 2. DIP peripheral GGO, in lower lung zones, possible cyst/emphysema, no honeycombing
27
Classic CTc findings for LIP
1. Bilat GGO 2. Centrilobular nodules 3. Bronchovascular bundle thickening and interlobular septal thickening 4. thin-walled cysts
28
Gene assoc with LAM
TSC1 and TSC2
29
Diagnostic test to differentiate berylliosis from sarcoid:
Lymph transfer test on BAL or beryllium lymphocyte proliferation test
30
CD4/CD8:
1. Normal= 1.5-2 2. Sarcoidosis: >3.5 has sens of 50% and spec of 94% 3. Organizing pneumonia: CD4/CD8 is decreased 4. HP: decreased CD4/CD8
31
Tumors associated with Birt Hogg Dube:
Renal cell carcinoma, oncocytic hybrid tumor, clear cell carcinoma
32
Birt Hogg Dube mutation
AD, chr 17 | BHD gene, encodes folliculin (tumor suppressor)
33
Classic Histopath finding with amiodarone lung toxicity
Foamy macrophages with fibrosis and lamellated inclusions
34
Lung toxicity with 5-ASA and sulfasalazine
Eosinophilia, OP, BO
35
Caplan Syndrome
Nodular reaction in patient with RA (or will develop RA in 5-10yr) exposed to coal dust. Focal lesion with necrotic center surrounded by lymphocytes and plasma cells and coal dust
36
Histology of silicotic nodule
Central dense hyalinzed collaged contained silica particle surrounded by concentric collagen fibers, peripheral thick capsule of dust-lade macrophages, lymphocytes, and collagen
37
Talc Pathology
Granulom with multinucleated giant cells in interstitium and pulmonary arteries (in IVDU). WITH birefringent talc crystals
38
Factors that determine degree of injury to upper and lower respiratory tract
1. particle size >10um filtered by upper pharyngeal anatomy, <5um bypass resp tract and desposit in lower resp tract 2. concentration 3. water solubility -water soluble react with mucosal surfaces of upper airway -less water soluble- lower resp tract and delayed parenchymal abnml 4. location- ventilation or not 5. physical properties
39
Water soluble inhalation injuries
immediate irritation and reactivity of conjunctival surfaces - Ammonia - SO2 - chlorine
40
Less water soluble agents
No acute, irritating symptoms, react with lower resp tract and cause delayed, severe parenchymal abnml - NO2 (silo fillers) - phosgene (welding, meth) - SO2
41
Classic BAL Findings PAP
Milky effluent - alveolar macrophages filled with PAS- + material - Lamellar bodies
42
Distinguish berrylium form sarcoid
Beryllium proliferative test (lymphocytes stimulated with soluble beryllium salts)
43
Pathology: HP
airway-centered, variably cellular chronic interstitial pneumonia, a lymphocyte-rich chronic bronchiolitis, and poorly formed nonnecrotizing granulomas distributed mainly within peribronchiolar interstitium
44
Skin manifestations of BHD
1. Fibrofolliculoma 2. trichodiscoma 3. Skin tag
45
Renal tumors seen with BHD
1. Oncotic hybrid tumor 2. RCC 3. Clear cell carcinoma 4. papillary renal cell carcinoma
46
Most common Ab in DM/PM and ILD
Anti-Jo (90% with this Ab have ILD)
47
Other DM/PM ILD Ab
SRP, Mi-2, amino-acyl transfer RNA synthetase
48
Amyositis DM/PM ILD
anti-MDA5 (rapidly progressive) | PL-12 (anti-synthetase)
49
Associated with myositis/scleroderma overlap
Anti-Ku
50
Assoc with severe necrotizing myopathy (DM/PM)
anti-SRP
51
CREST syndrome assoc with Ab:
anti-centromere
52
Homogeneous/diffuse ANA assoc with
SLE or MCTD
53
Nucleolar ANA assoc with:
Systemic sclerosis, PM
54
Centromere ANA assoc with:
Systemic sclerosis
55
Mixed Connective Tissue disease assoc with Ab:
anti-RNP, anti-U1
56
Sjogren Syndrome Ab
SSA (Ro), SSB (La)
57
Systemic scerlosis/scleroderma assoc with Ab:
Scl-70 (anti-DNA topoisomerase 1)
58
Characteristic features of IgG4 related disease
1. Dense lymphoplasmacytic infiltrate 2. Storiform fibrosis 3. obliterative phlebitis 4. IHC with IgG4+ cells
59
5 drugs cause drug-induced lupus
hydralazine, isoniazid, procainamide, quinidine, penicillamine
60
Major Drugs causing drug-induced HP
MTX, Taxanes | Abx, TNF alpha inhibitors
61
BCNU toxicity: | dose
timing: days to 17 years Dose: >1500mg/m2 (25-50% will develop pulmonary toxicity) Mech: oxidant-induced (decreased glutathione) ~90% mortality
62
Bleomycin- 6wk- 6mos | -with high O2 can awaken fibrosis/inflammation (binds histones)
>500 units | Increased risk with age >70, O2, radiation, abnormal renal function
63
Most common type of pulmonary toxicity with methotrexate
HSP
64
Amiodarone: dose for lung toxicity
Much more common at >400mg/d | -increased in >60yo
65
Anti-TNF alpha inhibitors: forms of toxicity
- granulomatous (sarcoid) ILD | - lymphohistiocytic reaction
66
Rituximab pulmonary toxicity
Can cause acute/subacute cellular ILD, profound lymphocytosis on BAL -also BOOP or pulmonary fibrosis

Pulmonary (14 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions